San Francisco startup Composition Therapeutics is additionally working on an oral, as soon as-each day GLP-1 drug termed GSBR-1290—the drug surpassed Wall Road’s expectations in June any time a mid-phase study confirmed regular weight loss of around 6% and it programs to start Yet another mid-stage demo toward the tip of the yr—that founder a… Read More